Elbasvir 50mg / Grazoprevir 100mg tablets
NHS hospitals in England used £50,639,397 of indicative cost of Elbasvir 50mg / Grazoprevir 100mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 31.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Elbasvir 50mg / Grazoprevir 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Elbasvir 50mg / Grazoprevir 100mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Southend Univ Hosp Nhs Foundation Trust | £9,648,082 |
| Manchester University Nhs Ft | £3,333,638 |
| Nottingham University Hospitals Trust | £1,873,650 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,764,151 |
| Leeds Teaching Hpls Nhs Trust | £1,253,156 |
| Aintree University Hospital Nhs Ft | £1,240,989 |
| Barts Health Nhs Trust | £1,204,489 |
| Imperial College Healthcare Nhs Trust | £1,119,324 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,113,241 |
| Western Sussex Hospitals Nhs Found Trust | £1,055,449 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.